Variation in human herpesvirus 6B telomeric integration, excision and transmission between tissues and individuals
- University of Leicester, United Kingdom
- MRC-University of Glasgow Centre for Virus Research, United Kingdom
- University of Groningen, Netherlands
- University of Manchester, United Kingdom
- Centre hospitalier de l'Université Laval, Canada
Abstract
Human herpesviruses 6A and 6B (HHV-6A/6B) are ubiquitous pathogens that persist lifelong in latent form and can cause severe conditions upon reactivation. They are spread by community-acquired infection of free virus (acqHHV6A/6B) and by germline transmission of inherited chromosomally-integrated HHV-6A/6B (iciHHV-6A/6B) in telomeres. We exploited a hypervariable region of the HHV-6B genome to investigate the relationship between acquired and inherited virus and revealed predominantly maternal transmission of acqHHV-6B in families. Remarkably, we demonstrate that some copies of acqHHV-6B in saliva from healthy adults gained a telomere, indicative of integration and latency, and that the frequency of viral genome excision from telomeres in iciHHV-6B carriers is surprisingly high and varies between tissues. In addition, newly formed short telomeres generated by partial viral genome release are frequently lengthened, particularly in telomerase-expressing pluripotent cells. Consequently, iciHHV-6B carriers are mosaic for different iciHHV-6B structures, including circular extra-chromosomal forms that have the potential to reactivate. Finally, we show transmission of an HHV-6B strain from an iciHHV-6B mother to her non-iciHHV-6B son. Altogether we demonstrate that iciHHV-6B can readily transition between telomere-integrated and free virus forms.
Data availability
Sequencing data have been deposited in GenBank under accession numbers: MW049313-MW049327.The HHV6 explorer is freely available at https://www.hhv6explorer.org/ and so The source code for the HHV6 explorer and HHV6 counter are available at https://github.com/colinveal/HHV6-Explorer.Other data generated or analysed during this study are included in the manuscript and supporting files.
Article and author information
Author details
Funding
Biotechnology and Biological Sciences Research Council (MIBTP 1645656)
- Michael L Wood
Medical Research Council (G0901657)
- Nicola J Royle
HHV-6 Foundation (Pilot grant)
- Nicola J Royle
Canadian Institutes of Health Research (MOP 123214)
- Louis Flamand
European Commission (FP7-242209- BIOSTAT-CHF)
- Adriaan A Voors
Medical Research Council (MC_UU_12014/3)
- Andrew J Davison
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Melanie M Brinkmann, Technische Universität Braunschweig, Germany
Ethics
Human subjects: The study was conducted in accordance with the Declaration of Helsinki and with approval by the relevant ethics committees as follows:The University of Leicester's Research Ethics Committee (refs: 10553-njr-genetics; njr-61d3).The BIOSTAT-CHF study was approved by the relevant ethics committee in each centre, all participants gave their written, informed consent to participate (Voors et al, 2016).
Version history
- Received: May 17, 2021
- Preprint posted: June 8, 2021 (view preprint)
- Accepted: September 20, 2021
- Accepted Manuscript published: September 21, 2021 (version 1)
- Version of Record published: October 5, 2021 (version 2)
Copyright
© 2021, Wood et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,192
- views
-
- 105
- downloads
-
- 5
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Variation in human herpesvirus 6B telomeric integration, excision and transmission between tissues and individuals
eLife 10:e70452.
https://doi.org/10.7554/eLife.70452
Further reading
-
- Cancer Biology
- Genetics and Genomics
Relapse of acute myeloid leukemia (AML) is highly aggressive and often treatment refractory. We analyzed previously published AML relapse cohorts and found that 40% of relapses occur without changes in driver mutations, suggesting that non-genetic mechanisms drive relapse in a large proportion of cases. We therefore characterized epigenetic patterns of AML relapse using 26 matched diagnosis-relapse samples with ATAC-seq. This analysis identified a relapse-specific chromatin accessibility signature for mutationally stable AML, suggesting that AML undergoes epigenetic evolution at relapse independent of mutational changes. Analysis of leukemia stem cell (LSC) chromatin changes at relapse indicated that this leukemic compartment underwent significantly less epigenetic evolution than non-LSCs, while epigenetic changes in non-LSCs reflected overall evolution of the bulk leukemia. Finally, we used single-cell ATAC-seq paired with mitochondrial sequencing (mtscATAC) to map clones from diagnosis into relapse along with their epigenetic features. We found that distinct mitochondrially-defined clones exhibit more similar chromatin accessibility at relapse relative to diagnosis, demonstrating convergent epigenetic evolution in relapsed AML. These results demonstrate that epigenetic evolution is a feature of relapsed AML and that convergent epigenetic evolution can occur following treatment with induction chemotherapy.
-
- Computational and Systems Biology
- Genetics and Genomics
We propose a new framework for human genetic association studies: at each locus, a deep learning model (in this study, Sei) is used to calculate the functional genomic activity score for two haplotypes per individual. This score, defined as the Haplotype Function Score (HFS), replaces the original genotype in association studies. Applying the HFS framework to 14 complex traits in the UK Biobank, we identified 3619 independent HFS–trait associations with a significance of p < 5 × 10−8. Fine-mapping revealed 2699 causal associations, corresponding to a median increase of 63 causal findings per trait compared with single-nucleotide polymorphism (SNP)-based analysis. HFS-based enrichment analysis uncovered 727 pathway–trait associations and 153 tissue–trait associations with strong biological interpretability, including ‘circadian pathway-chronotype’ and ‘arachidonic acid-intelligence’. Lastly, we applied least absolute shrinkage and selection operator (LASSO) regression to integrate HFS prediction score with SNP-based polygenic risk scores, which showed an improvement of 16.1–39.8% in cross-ancestry polygenic prediction. We concluded that HFS is a promising strategy for understanding the genetic basis of human complex traits.
